Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial

Published:2014-12-09 Issue:1 Volume:3 Page:e00094
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Betts Joanna C.¹,Mayer Ruth J.²,Tal-Singer Ruth²,Warnock Linda¹,Clayton Chris¹,Bates Stewart¹,Hoffman Bryan E.²,Larminie Christopher¹,Singh Dave³

Affiliation:

1. R&D; GlaxoSmithKline; Stevenage United Kingdom

2. R&D; GlaxoSmithKline; King of Prussia Pennsylvania USA

3. University of Manchester; Medicines Evaluation Unit; University Hospital of South Manchester Foundations Trust; Manchester United Kingdom

Funder

GSK

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Reference31 articles.

1. C-reactive protein and lung diseases;Agassandian;Int J Biochem Cell Biol,2014

2. Synergistic effects of p38 mitogen-activated protein kinase inhibition with a corticosteroid in alveolar macrophages from patients with chronic obstructive pulmonary disease;Armstrong;J Pharmacol Exp Ther,2011

3. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers;Bafadhel;Am J Respir Crit Care Med,2011

4. The role of p38 mitogen-activated protein kinase in IL-1beta transcription;Baldasarre;J Immunol,1999

5. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor;Berghe;J Biol Chem,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular changes underlying pulmonary emphysema and chronic bronchitis in Chronic Obstructive Pulmonary Disease: An updated review;HISTOL HISTOPATHOL;2024

2. p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics;Cell Communication and Signaling;2023-11-02

3. Mucus hypersecretion in COVID-19 patients: signaling pathway and related targeted therapies;SCIENTIA SINICA Vitae;2023-06-09

4. The antioxidant N-acetylcysteine promotes immune response and inhibits epithelial-mesenchymal transition to alleviate pulmonary fibrosis in chronic obstructive pulmonary disease by suppressing the VWF/p38 MAPK axis;Molecular Medicine;2021-09-03

5. A Novel Processing-Free Method for RNAseq Analysis of Spontaneous Sputum in Chronic Obstructive Pulmonary Disease;Frontiers in Pharmacology;2021-08-19